Skip to main content

Table 2 Baseline clinical, laboratory and medication-related characteristics of the HIV-infected children on ART at Debre-Markos Referral Hospital, Northwest Ethiopia, from January 1, 2005 to March 31, 2019 (N = 408)

From: Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study

CharacteristicsCategoriesFrequency (N)Percentage (%)
History of PMTCTYes5613.7
No22956.1
Not recorded12330.2
History of OIsYes21552.7
No19347.3
Weight for ageNormal20750.7
Underweight20149.3
Weight for heightNormal31176.2
Wasted9723.8
Height for ageNormal19748.3
Stunted21151.7
WHO clinical stageStage I and II21252.0
Stage III and IV19648.0
CD4 counts or %Above the threshold27767.9
Below the thresheold13132.1
Hgb level≥ 10 g/dl36689.7
<  10 g/dl4210.3
ART eligibility criteriaTest and treat6716.4
CD4 or WHO staging34183.6
Type of regimen at baselineNevirapine base27266.7
Efaveraze base8621.1
Protease inhibitor base5012.3
Ever taking IPTYes21753.2
No19146.8
ART adherenceGood32178.7
Fair/ poor8721.3
Past OI prophylaxisYes24860.8
No16039.2
ART side effectYes194.7
No38995.3
Regimen changeYes8420.6
No32479.4
Treatment failureYes204.9
No38895.1
Functional statusWorking15353.3
Ambulatory11339.4
Bed ridden217.3
Developmental statusAppropriate7360.3
Delayed4133.9
Regressed75.8
  1. PMTCT Prevention of Mother To Child Transmission, OIs Opportunistic Infections, WHO World Health Organization, Hgb Hemoglobin, CD4 Cluster of differentiation 4, and ART Antiretroviral Therapy